Chempartner Pharmatech Overview
- Year Founded
-
2000

- Status
-
Public
- Employees
-
1,916

- Stock Symbol
-
300149

- Investments
-
2
- Share Price
-
$0.79
- (As of Tuesday Closing)
Chempartner Pharmatech General Information
Description
Chempartner Pharmatech Co Ltd is engaged in the research, development, production, and operation of prebiotics, micro-ecological medical, and biopharmaceuticals.
Contact Information
Website
www.cppt.com.cnCorporate Office
- Guangzhou Exchange Square
- 28th Floor No.268, Dongfeng Zhong Road
- Guangzhou, Guangdong 510000
- China
Corporate Office
- Guangzhou Exchange Square
- 28th Floor No.268, Dongfeng Zhong Road
- Guangzhou, Guangdong 510000
- China
Chempartner Pharmatech Stock Performance
As of 22-Apr-2025, Chempartner Pharmatech’s stock price is $0.79. Its current market cap is $392M with 498M shares.
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.79 | $0.79 | $0.51 - $1.36 | $392M | 498M | 13.8M | -$0.26 |
Chempartner Pharmatech Financials Summary
As of 30-Sep-2024, Chempartner Pharmatech has a trailing 12-month revenue of $141M.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 494,624 | 537,810 | 801,650 | 1,315,806 |
Revenue | 140,805 | 160,902 | 196,982 | 261,833 |
EBITDA | (134,142) | (110,763) | 144,957 | (14,201) |
Net Income | (131,943) | (129,579) | 53,846 | (62,295) |
Total Assets | 307,552 | 343,414 | 551,931 | 661,676 |
Total Debt | 68,834 | 89,628 | 140,042 | 274,081 |
Chempartner Pharmatech Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Chempartner Pharmatech Signals
Chempartner Pharmatech Acquisitions (2)
Chempartner Pharmatech’s most recent deal was a Merger/Acquisition with ChemPartner for . The deal was made on 16-Aug-2018.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
ChemPartner | 16-Aug-2018 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
Shanghai Ruizhi Chemistry Research | 13-Jun-2017 | Merger/Acquisition | Other Chemicals and Gases |
Chempartner Pharmatech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile

Pharmaceuticals
Industry
Rank
Percentile

Biotechnology
Subindustry
Rank
Percentile

Chempartner Pharmatech Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
ChemPartner | Shanghai, China | 2002 |
Chempartner Pharmatech FAQs
-
When was Chempartner Pharmatech founded?
Chempartner Pharmatech was founded in 2000.
-
Where is Chempartner Pharmatech headquartered?
Chempartner Pharmatech is headquartered in Guangzhou, China.
-
What is the size of Chempartner Pharmatech?
Chempartner Pharmatech has 1,916 total employees.
-
What industry is Chempartner Pharmatech in?
Chempartner Pharmatech’s primary industry is Biotechnology.
-
Is Chempartner Pharmatech a private or public company?
Chempartner Pharmatech is a Public company.
-
What is Chempartner Pharmatech’s stock symbol?
The ticker symbol for Chempartner Pharmatech is 300149.
-
What is the current stock price of Chempartner Pharmatech?
As of 22-Apr-2025 the stock price of Chempartner Pharmatech is $0.79.
-
What is the current market cap of Chempartner Pharmatech?
The current market capitalization of Chempartner Pharmatech is $392M.
-
What is Chempartner Pharmatech’s current revenue?
The trailing twelve month revenue for Chempartner Pharmatech is $141M.
-
What is Chempartner Pharmatech’s annual earnings per share (EPS)?
Chempartner Pharmatech’s EPS for 12 months was -$0.26.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »